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background: Stroke is the leading cause of long term disability and second leading cause of death worldwide. The effectiveness of primary 
and secondary prevention of stroke by antihypertensive medications is well validated however support for permissive hypertension in the 
early course of acute ischemic stroke has been questioned.
Methods: A systematic review of PubMed, Cochrane, and Embase databases was conducted for all randomized clinical trials comparing 
antihypertensive agents (i.e. calcium channel blockers (CCB), angiotensin receptor blockers (ARBs), prostacyclin (PR), and combined 
regimens using angiotensin converting enzyme inhibitors (ACE-I), CCB and diuretics if required) versus placebo within 48 hours after acute 
ischemic stroke using standard approach for meta-analysis. The main outcome was all cause mortality.
Results: We analyzed data from 18 trials published from 1987 to 2014 (15 trials used CCBs, 1- ARB, 1-PR and 1 using combined regimen) 
involving a total of 10132 patients. There was a 13% relative risk reduction in all-cause mortality in the placebo group compared with 
the antihypertensive treatment group [1.13 (95% confidence interval 1.03 - 1.25) p=0.014]. There was neither significant heterogeneity 
(p=0.819) nor publication bias (p=0.739) noted among the studies.
conclusion: Immediate antihypertensive treatment after acute ischemic stroke increases mortality which validates the practice of 
permissive hypertension.
